hydrazine has been researched along with Anemia, Diamond-Blackfan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choy, JS; Hakami, W; Keyvanfar, K; Larochelle, A; Li, Y; Linask, K; Qanash, H; Smith, RH; Young-Baird, S; Zou, J | 1 |
| Brümmendorf, TH; Ehninger, G; Jakob, C; Platzbecker, U; Schleyer, E; Siegert, G; Trautmann, K; von Grünhagen, U | 1 |
2 other study(ies) available for hydrazine and Anemia, Diamond-Blackfan
| Article | Year |
|---|---|
Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia.
Topics: Anemia, Diamond-Blackfan; Animals; Base Sequence; Benzoates; Cell Differentiation; Cell Line; Erythroid Cells; Erythropoiesis; Humans; Hydrazines; Induced Pluripotent Stem Cells; Intracellular Space; Iron; Mice, Inbred NOD; Mice, SCID; Models, Biological; Mutation; Pyrazoles | 2021 |
Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Diamond-Blackfan; Benzoates; Cardiology; Dyskeratosis Congenita; Female; Humans; Hydrazines; Male; Megakaryocytes; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Treatment Outcome | 2012 |